IGKC	gene symbol: IGKC. Functionality: enables antigen binding activity, part of igg immunoglobulin complex. Phenotype: associated with adaptive immune response; potential role in her2-positive breast cancer. 
TMSB10	gene symbol: TMSB10. Functionality: enables actin monomer binding, regulates cell migration, sequesters actin monomers, located in cytoskeleton, active in cytoplasm. Phenotype: related to altered cell migration dynamics, potentially influencing cancer metastasis in her2-positive breast cancer. 
ERBB2	gene symbol: ERBB2. Functionality: egf receptor family tyrosine kinase, heterodimer formation, downstream signalling pathway activation Phenotype: her2-positive breast cancer, gene amplification and overexpression, allelic variations 
IGHG3	gene symbol: IGHG3. Functionality: antigen binding, immunoglobulin receptor binding, complement activation Phenotype: her2-positive breast cancer progression, immune response modulation 
IGLC2	gene symbol: IGLC2. Functionality: antigen binding, immunoglobulin mediated immune response Phenotype: her2-positive breast cancer 
IGHA1	gene symbol: IGHA1. Functionality: immunoglobulin receptor binding, glomerular filtration, respiratory burst regulation. Phenotype: involvement in immune response, iga complex formation, extracellular space activity. 
GAPDH	gene symbol: GAPDH. Functionality: catalyzes phosphorylation in glycolysis, uracil dna glycosylase activity, antimicrobial peptide. Phenotype: expression in her2-positive breast cancer; associated with glycolysis and cellular metabolism. 
ACTB	gene symbol: ACTB. Functionality: cell motility, structure, integrity, intercellular signaling, contractile apparatus. Phenotype: baraitser-winter syndrome 1; intellectual disability, distinctive facial appearance. 
IGLC3	gene symbol: IGLC3. Functionality: antigen binding, immunoglobulin mediated immune response, part of igg complex Phenotype: associated with immune response modulation 
IGHM	gene symbol: IGHM. Functionality: encodes mu heavy chain c region, defines igm isotype, antigen recognition, isotype switching. Phenotype: antibody production, naive b cells express igm, involved in immune response. 
SERF2	gene symbol: SERF2. Functionality: protein destabilization, cytosol and nucleus localization. Phenotype: her2-positive breast cancer progression. 
PSMB3	gene symbol: PSMB3. Functionality: part of 20s core proteasome; atp/ubiquitin-dependent peptide cleavage; processes class i mhc peptides. Phenotype: linked to her2-positive breast cancer; involved in trinucleotide repeat expansion linked to neurological diseases. 
PFN1	gene symbol: PFN1. Functionality: actin-binding, regulates actin polymerization, responds to signals, involved in cytoskeletal dynamics. Phenotype: associated with her2-positive breast cancer, linked to miller-dieker syndrome, may play a role in huntington disease. 
ACTG1	gene symbol: ACTG1. Functionality: encodes cytoplasmic actin involved in cell motility, cytoskeleton maintenance. Phenotype: associated with dfna20/26 hearing loss, baraitser-winter syndrome. 
KRT19	gene symbol: KRT19. Functionality: encodes keratin family member; provides structural integrity to epithelial cells; unpaired acidic cytokeratin. Phenotype: expressed in her2-positive breast cancer; marker for epithelial cell differentiation; associated with cancer prognosis. 
RACK1	gene symbol: RACK1. Functionality: cyclin binding, enzyme binding, protein domain specific binding, signal transduction regulation, protein metabolic process regulation, vesicle-mediated transport regulation. Phenotype: her2-positive breast cancer association, cell signaling modulation, cellular growth and proliferation influence. 
MUCL1	gene symbol: MUCL1. Functionality: mucl1 encodes a mucin-like protein involved in cell adhesion and signaling, potentially playing a role in breast cancer pathogenesis. Phenotype: altered expression in her2-positive breast cancer may influence tumor growth and progression. 
CISD3	gene symbol: CISD3. Functionality: regulates electron transport, oxidative phosphorylation Phenotype: her2-positive breast cancer involvement 
APOE	gene symbol: APOE. Functionality: binds to liver receptors, essential for triglyceride-rich lipoprotein catabolism. Phenotype: familial dysbetalipoproteinemia; increased plasma cholesterol and triglycerides. 
MIEN1	gene symbol: MIEN1. Functionality: negative regulation of apoptosis; positive regulation of cell migration and filopodium assembly; located in cytosolic and plasma membrane Phenotype: contributes to her2-positive breast cancer progression; associated with increased cell motility and survivability 
SSR4	gene symbol: SSR4. Functionality: encodes delta subunit of translocon-associated protein complex; involved in translocating proteins across endoplasmic reticulum membrane. Phenotype: associated with protein translocation defects; potential link with her2-positive breast cancer. 
CALR	gene symbol: CALR. Functionality: chaperone protein, endoplasmic reticulum, protein folding, calcium homeostasis, transcription regulation. Phenotype: systemic lupus erythematosus, autoantibody titers, myeloproliferative neoplasms. 
PSAP	gene symbol: PSAP. Functionality: encodes protein for surfactant homeostasis, binds carbohydrates on lipids and microorganisms. Phenotype: associated with idiopathic pulmonary fibrosis; potential role in her2-positive breast cancer. 
CTSD	gene symbol: CTSD. Functionality: proteolytic activity, protein turnover, hormone activation, growth factor activation. Phenotype: her2-positive breast cancer, neuronal ceroid lipofuscinosis-10. 
FTL	gene symbol: FTL. Functionality: encodes ferritin light subunit; intracellular iron storage; affects iron uptake/release; stores iron soluble/nontoxic. Phenotype: neurodegenerative diseases; hyperferritinemia-cataract syndrome; her2-positive breast cancer involvement. 
FTH1	gene symbol: FTH1. Functionality: encodes heavy subunit of ferritin; major intracellular iron storage protein; affects iron uptake and release; stores iron in soluble, nontoxic state. Phenotype: associated with neurodegenerative diseases; influences her2-positive breast cancer through iron metabolism. 
TPT1	gene symbol: TPT1. Functionality: regulates cellular growth, proliferation, apoptosis; stabilizes microtubules Phenotype: role in carcinogenesis; upregulated in cancer cells; affects mitotic, meiotic divisions 
PTPRF	gene symbol: PTPRF. Functionality: protein tyrosine phosphatase, signaling in cell growth, differentiation, mitotic cycle, oncogenic transformation, epithelial cell-cell contacts, beta-catenin signaling. Phenotype: increased expression in insulin-resistant tissues, potential role in insulin resistance pathogenesis. 
UBA52	gene symbol: UBA52. Functionality: encodes fusion protein of ubiquitin and ribosomal protein l40; involved in protein degradation, chromatin maintenance, gene regulation, stress response. Phenotype: overexpression linked to her2-positive breast cancer; impacts cellular growth and survival pathways. 
P4HB	gene symbol: P4HB. Functionality: prolyl hydroxylation, disulfide isomerase, chaperone, nitric oxide regulation, microsomal triglyceride transfer. Phenotype: protein folding, collagen stability, her2-positive breast cancer progression. 
BEST1	gene symbol: BEST1. Functionality: chloride ion channel, regulates l-type calcium-ion channels, permeable to bicarbonate ion transport. Phenotype: juvenile-onset vitelliform macular dystrophy, adult-onset vitelliform macular dystrophy, retinopathies. 
HLA-B	gene symbol: HLA-B. Functionality: immune response modulation, peptide presentation, cell surface expression Phenotype: transplant rejection, disease susceptibility, immune-related conditions 
FAU	gene symbol: FAU. Functionality: encodes fusion protein with ubiquitin-like protein and ribosomal protein s30; involved in protein synthesis and antimicrobial activity. Phenotype: associated with her2-positive breast cancer; potential influence on cancer cell growth and survival. 
SLC9A3R1	gene symbol: SLC9A3R1. Functionality: regulates sodium/hydrogen exchange, interacts with cystic fibrosis transmembrane conductance regulator, g-protein coupled receptors, and cytoskeletal proteins. Phenotype: hypophosphatemic nephrolithiasis/osteoporosis type 2, implicated in her2-positive breast cancer. 
FN1	gene symbol: FN1. Functionality: cell adhesion, migration, embryogenesis, wound healing, coagulation, defense, metastasis Phenotype: her2-positive breast cancer, tissue remodeling, metastasis promotion 
COL1A1	gene symbol: COL1A1. Functionality: encodes pro-alpha1 chains of type i collagen, forms triple helix, structural role in connective tissues. Phenotype: associated with osteogenesis imperfecta, ehlers-danlos syndrome, caffey disease, idiopathic osteoporosis, dermatofibrosarcoma protuberans. 
EEF2	gene symbol: EEF2. Functionality: gtp-binding, translation elongation, protein synthesis, ribosomal translocation. Phenotype: her2-positive breast cancer, protein synthesis disruption. 
IGHG4	gene symbol: IGHG4. Functionality: enables antigen binding, immunoglobulin receptor binding, involved in antibacterial humoral response, complement activation. Phenotype: involvement in immune response, potential implications in her2-positive breast cancer due to immune modulation. 
CALML5	gene symbol: CALML5. Functionality: calcium binding, conformational change, epidermis expression, keratinocyte differentiation, transglutaminase 3 association. Phenotype: her2-positive breast cancer, epidermal differentiation, keratinocyte function. 
CD74	gene symbol: CD74. Functionality: associates with mhc class ii, regulates antigen presentation, serves as mif receptor, initiates survival pathways, cell proliferation, interacts with app, suppresses amyloid beta production. Phenotype: involved in immune response modulation, influences cell proliferation, linked to her2-positive breast cancer proliferation and survival pathways. 
B2M	gene symbol: B2M. Functionality: encodes serum protein associated with mhc class i; involved in immune response and antimicrobial activity. Phenotype: mutation leads to hypercatabolic hypoproteinemia; implicated in amyloid fibril formation. 
FASN	gene symbol: FASN. Functionality: catalyzes synthesis of palmitate from acetyl-coa and malonyl-coa using nadph. Phenotype: linked to her2-positive breast cancer; fusion with er-alpha observed in some cancer cell lines. 
S100A9	gene symbol: S100A9. Functionality: calcium-binding protein, regulates cell cycle, differentiation, inhibits casein kinase, antimicrobial activity. Phenotype: involvement in inflammation, immune response, associated with her2-positive breast cancer, cystic fibrosis. 
MGP	gene symbol: MGP. Functionality: inhibits ectopic tissue calcification; secreted by chondrocytes and vascular smooth muscle cells; vitamin k-dependent. Phenotype: calcification of vasculature; associated with cardiovascular disease; keutel syndrome; affects her2-positive breast cancer development. 
CFL1	gene symbol: CFL1. Functionality: actin-binding, polymerize f-actin, depolymerize g-actin, ph-dependent, phosphorylation by lim kinase, cytoskeleton reorganization, translocation of actin-cofilin complex. Phenotype: her2-positive breast cancer, actin cytoskeleton dynamics, cell motility, tumor progression, metastasis. 
PSMD3	gene symbol: PSMD3. Functionality: non-atpase subunit of 19s proteasome regulator, peptide cleavage, ubiquitin-dependent process. Phenotype: associated with her2-positive breast cancer, affects neutrophil count. 
IGHG1	gene symbol: IGHG1. Functionality: fc-gamma receptor binding, antibody-dependent cytotoxicity, complement-dependent cytotoxicity, igg complex component Phenotype: immune response modulation, her2-positive breast cancer progression 
HLA-A	gene symbol: HLA-A. Functionality: presents intracellular peptides to cytotoxic t cells, involved in immune response and transplantation compatibility. Phenotype: influences susceptibility to infectious diseases, immune response variation, and transplant rejection. 
S100A6	gene symbol: S100A6. Functionality: calcium-binding protein, regulates cell cycle, differentiation, insulin release, prolactin secretion, exocytosis. Phenotype: involved in her2-positive breast cancer; altered expression linked to melanoma. 
MYL6	gene symbol: MYL6. Functionality: encodes myosin alkali light chain, part of atpase motor protein in muscle. Phenotype: involvement in smooth muscle contraction and cell motility. 
COL1A2	gene symbol: COL1A2. Functionality: encodes pro-alpha2 chain of type i collagen, involved in connective tissue structure. Phenotype: linked to osteogenesis imperfecta, ehlers-danlos syndrome, idiopathic osteoporosis, marfan syndrome. 
PHB	gene symbol: PHB. Functionality: cellular senescence, tumor suppression, antiproliferative activity Phenotype: her2-positive breast cancer regulation, altered cell proliferation 
TAGLN2	gene symbol: TAGLN2. Functionality: tumor suppressor, smooth muscle differentiation marker, multiple isoforms Phenotype: her2-positive breast cancer involvement, potential tumor suppression 
HLA-E	gene symbol: HLA-E. Functionality: hla-e presents peptides for immune recognition, regulates natural killer and t-cell responses. Phenotype: linked to immune modulation in her2-positive breast cancer, affects tumor immune evasion. 
HLA-C	gene symbol: HLA-C. Functionality: hla-c presents peptides to immune system; binds peptides in er; participates in antigen processing. Phenotype: influences immune response variability; associated with infectious disease outcomes; relevant in transplantation compatibility. 
KRT7	gene symbol: KRT7. Functionality: encodes type ii cytokeratin protein, part of keratin gene family, involved in epithelial tissue differentiation, specifically expressed in simple epithelia. Phenotype: expression associated with her2-positive breast cancer, observed in epithelial tissues lining internal organ cavities and gland ducts. 
CD63	gene symbol: CD63. Functionality: cell surface protein; mediates signal transduction; regulates cell development, activation, growth, motility; complexes with integrins; associated with tumor progression. Phenotype: blood platelet activation marker; hermansky-pudlak syndrome deficiency; linked to tumor progression. 
SYNGR2	gene symbol: SYNGR2. Functionality: membrane protein, regulates membrane traffic, tyrosine phosphorylation. Phenotype: her2-positive breast cancer, altered cell signaling, potential tumor progression. 
STARD3	gene symbol: STARD3. Functionality: lipid trafficking, cholesterol export, late endosome localization Phenotype: her2-positive breast cancer 
PABPC1	gene symbol: PABPC1. Functionality: poly(a) binding, mrna stability, translation initiation, ribosome recruitment. Phenotype: her2-positive breast cancer, enhanced translation, mrna decay regulation. 
GPX4	gene symbol: GPX4. Functionality: catalyzes reduction of hydroperoxides; protects against oxidative damage; lipid peroxidation defense; supports sperm development. Phenotype: involved in her2-positive breast cancer; associated with sedaghatian type spondylometaphyseal dysplasia. 
GRB7	gene symbol: GRB7. Functionality: adapter protein interacting with receptor tyrosine kinases, egfr, ephrin receptors; involved in integrin signaling, cell migration; binds fak. Phenotype: associated with her2-positive breast cancer; impacts cancer cell proliferation, invasion. 
SLC25A6	gene symbol: SLC25A6. Functionality: transports adp/atp across mitochondrial membrane, part of permeability transition pore complex, induces apoptosis. Phenotype: altered expression linked to her2-positive breast cancer, affects cellular energy metabolism and apoptosis regulation. 
AEBP1	gene symbol: AEBP1. Functionality: transcriptional repressor, adipogenesis, smooth muscle cell differentiation, wound healing, abdominal wall development. Phenotype: her2-positive breast cancer, glioblastoma association. 
GNAS	gene symbol: GNAS. Functionality: imprinted gene; alternative splicing; g-protein signaling; adenylyl cyclase activation. Phenotype: pseudohypoparathyroidism; albright hereditary osteodystrophy; mccune-albright syndrome; fibrous dysplasia; pituitary tumors. 
NDUFB9	gene symbol: NDUFB9. Functionality: subunit of mitochondrial oxidative phosphorylation complex i, involved in electron transport and nadh dehydrogenation. Phenotype: complex i deficiency related to oxidative phosphorylation disorders, including neonatal disease, cardiomyopathy, liver disease, neurodegenerative disorders. 
EDF1	gene symbol: EDF1. Functionality: regulates endothelial cell differentiation, lipid metabolism, hormone-induced cardiomyocyte hypertrophy, transcriptional coactivator. Phenotype: her2-positive breast cancer, altered cell differentiation and metabolism. 
CRIP2	gene symbol: CRIP2. Functionality: transcription factor, zinc-binding, differentiation, smooth muscle. Phenotype: her2-positive breast cancer, altered muscle tissue differentiation. 
DDX5	gene symbol: DDX5. Functionality: rna helicase, transcription coregulator, splicing regulator, small rna processing. Phenotype: cancer development, her2-positive breast cancer involvement. 
OAZ1	gene symbol: OAZ1. Functionality: regulates polyamine levels, inhibits ornithine decarboxylase, binds antizymes, impacts cell growth. Phenotype: influences cell proliferation, potential impact on tumor growth in her2-positive breast cancer. 
EIF4G1	gene symbol: EIF4G1. Functionality: component of eif4f complex; recruits mrna to ribosome; initiates protein synthesis; catalyzes mrna cap recognition and unwinding. Phenotype: influences mrna translation; associated with her2-positive breast cancer; affects cell proliferation. 
LMNA	gene symbol: LMNA. Functionality: nuclear lamina protein, mitosis, nuclear stability, chromatin structure, gene expression. Phenotype: emery-dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, charcot-marie-tooth disease, hutchinson-gilford progeria syndrome. 
GNB2	gene symbol: GNB2. Functionality: encodes beta subunit of g proteins; regulates alpha subunits, signal transduction receptors and effectors. Phenotype: associated with signal transduction in her2-positive breast cancer. 
CST3	gene symbol: CST3. Functionality: cysteine protease inhibitor, antimicrobial activity, gene mutation linked to amyloid angiopathy. Phenotype: reduced expression in atherosclerotic and aneurysmal lesions, presence in biological fluids, expressed in most organs. 
PCGF2	gene symbol: PCGF2. Functionality: negative regulator of transcription, tumor suppressor, maintains repression of genes in embryogenesis, cell cycles, tumorigenesis. Phenotype: limited expression in normal neural tissues, detected in various tumor cells, influences lymphocyte differentiation, migration, immune responses. 
SDC1	gene symbol: SDC1. Functionality: transmembrane heparan sulfate proteoglycan; cell binding; signaling; cytoskeletal organization; internalization of hiv-1 tat; cell proliferation; migration; cell-matrix interactions. Phenotype: altered expression detected in tumor types; associated with her2-positive breast cancer. 
S100A11	gene symbol: S100A11. Functionality: calcium-binding, cell cycle regulation, differentiation, motility, invasion, tubulin polymerization. Phenotype: tumor metastasis, her2-positive breast cancer association. 
PRDX1	gene symbol: PRDX1. Functionality: antioxidant enzyme; reduces hydrogen peroxide; antiviral activity; cell protection; cancer progression. Phenotype: her2-positive breast cancer; increased cell proliferation; potential tumor progression. 
GRINA	gene symbol: GRINA. Functionality: calcium channel activity, apoptotic signaling, er calcium ion homeostasis Phenotype: her2-positive breast cancer, altered apoptosis, calcium regulation 
ATP6V0B	gene symbol: ATP6V0B. Functionality: encodes v0 domain of v-atpase, mediates organelle acidification, essential for protein sorting, zymogen activation, endocytosis, synaptic vesicle function. Phenotype: associated with altered intracellular ph regulation, impacts cellular processes in her2-positive breast cancer. 
TFF3	gene symbol: TFF3. Functionality: secretory protein, gastrointestinal mucosa protection, mucus layer stabilization, epithelial healing. Phenotype: her2-positive breast cancer, expressed in goblet cells. 
HLA-DRA	gene symbol: HLA-DRA. Functionality: antigen presentation, immune response, peptide binding, t cell activation Phenotype: immune system modulation, antigen presenting cell activity, infection response 
EEF1D	gene symbol: EEF1D. Functionality: encodes elongation factor-1 complex subunit; guanine nucleotide exchange factor; interacts with hiv-1 tat. Phenotype: associated with her2-positive breast cancer; affects protein translation dynamics; potential role in cancer cell proliferation. 
AZGP1	gene symbol: AZGP1. Functionality: cell adhesion, sensory perception, extracellular space localization. Phenotype: associated with prostate carcinoma, gastrointestinal cancer, kidney failure, liver cirrhosis, lung adenocarcinoma, obesity. 
PPP1CA	gene symbol: PPP1CA. Functionality: encodes catalytic subunit of protein phosphatase 1, involved in dephosphorylation, regulates cell division, glycogen metabolism, muscle contractility, protein synthesis, viral transcription. Phenotype: implications in cardiac function, diabetes, cancer, increased activity in heart failure. 
FLNA	gene symbol: FLNA. Functionality: actin-binding, cytoskeleton remodeling, cell shape and migration modulation, interaction with integrins, receptor complexes. Phenotype: periventricular nodular heterotopias, otopalatodigital syndromes, frontometaphyseal dysplasia, melnick-needles syndrome, x-linked intestinal pseudoobstruction. 
COL3A1	gene symbol: COL3A1. Functionality: encodes pro-alpha1 chains of type iii collagen; found in connective tissues. Phenotype: associated with ehlers-danlos syndrome type iv; aortic and arterial aneurysms. 
ATP5E	gene symbol: ATP5E. Functionality: encodes epsilon subunit of mitochondrial atp synthase f1 catalytic core; involved in atp synthesis via oxidative phosphorylation. Phenotype: altered energy metabolism; potential contribution to her2-positive breast cancer progression. 
SPDEF	gene symbol: SPDEF. Functionality: ets family transcription factor, androgen-independent transactivator of psa promoter, involved in tumor progression. Phenotype: high expression in prostate, brain, breast, lung, ovarian tumors; potential target for cancer therapy. 
AP000769.1	gene symbol: AP000769.1. Functionality: potential involvement in her2-positive pathways. Phenotype: her2-positive breast cancer; abnormal cell proliferation and aggressive tumor growth. 
ALDOA	gene symbol: ALDOA. Functionality: glycolytic enzyme, catalyzes conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Phenotype: associated with glycogen storage disease xii, hemolytic anemia; influences progression of multiple cancers including her2-positive breast cancer. 
PLXNB2	gene symbol: PLXNB2. Functionality: transmembrane receptor, axon guidance, cell migration, semaphorin response. Phenotype: her2-positive breast cancer, altered cell migration and signaling. 
TAGLN	gene symbol: TAGLN. Functionality: actin-binding, calcium-independent contraction, tumor suppressor Phenotype: smooth muscle differentiation, cytoskeletal changes, tumor development 
TUBA1B	gene symbol: TUBA1B. Functionality: gtp binding, gtpase activity, ubiquitin ligase binding, cytoskeleton structural constituent, microtubule organization Phenotype: her2-positive breast cancer cell proliferation, altered cell division, microtubule stabilization 
APOC1	gene symbol: APOC1. Functionality: involved in hdl and vldl metabolism, inhibits cholesteryl ester transfer protein. Phenotype: associated with lipid metabolism disorders, potential role in her2-positive breast cancer. 
PRRC2A	gene symbol: PRRC2A. Functionality: involvement in inflammatory processes, potential role in autoimmune disorders, gene within mhc class iii region. Phenotype: association with iddm age-at-onset, potential link to rheumatoid arthritis, possible impact on pancreatic beta-cell destruction. 
LAPTM5	gene symbol: LAPTM5. Functionality: encodes transmembrane receptor linked to lysosomes, involved in hematopoiesis. Phenotype: altered expression associated with immune cell function and cancer progression. 
PTMS	gene symbol: PTMS. Functionality: histone binding, regulates transcription and apoptosis, active in nucleus Phenotype: potential role in her2-positive breast cancer proliferation 
KRT18	gene symbol: KRT18. Functionality: encodes type i intermediate filament keratin 18, partners with keratin 8, expressed in epithelial tissues. Phenotype: linked to cryptogenic cirrhosis, associated with her2-positive breast cancer. 
IFI27	gene symbol: IFI27. Functionality: rna polymerase ii transcription regulation, identical protein binding, lamin binding, defense response, ubiquitination, pyroptotic response Phenotype: her2-positive breast cancer involvement, mitochondrial function, transcriptional regulation 
PLD3	gene symbol: PLD3. Functionality: catalyzes hydrolysis of membrane phospholipids, influences amyloid-beta precursor protein processing. Phenotype: associated with increased alzheimer disease risk, involvement in her2-positive breast cancer. 
ADAM15	gene symbol: ADAM15. Functionality: cell adhesion, proteolytic processing, signaling Phenotype: her2-positive breast cancer 
C1QA	gene symbol: C1QA. Functionality: encodes a-chain of c1q in complement system, associates with c1r and c1s. Phenotype: deficiency linked to lupus erythematosus, glomerulonephritis, her2-positive breast cancer. 
AES	gene symbol: AES. Functionality: repressor of gene expression, interacts with groucho/tle family, involved in transcriptional regulation. Phenotype: implicated in her2-positive breast cancer, neurogenesis, embryonic development. 
TSPO	gene symbol: TSPO. Functionality: cholesterol transport into mitochondria, steroidogenesis initiation, benzodiazepine interaction. Phenotype: her2-positive breast cancer progression, mitochondrial function modulation. 
MLLT6	gene symbol: MLLT6. Functionality: histone binding, nucleosome binding, transcription regulation by rna polymerase ii. Phenotype: involved in renal potassium, sodium excretion, and water absorption. 
TAPBP	gene symbol: TAPBP. Functionality: mediates mhc class i and tap interaction; essential for peptide loading; maintains membrane proteins in er. Phenotype: associated with her2-positive breast cancer; influences immune response modulation. 
SCAND1	gene symbol: SCAND1. Functionality: binds scan domain, regulates transcription factor myeloid zinc finger 1b. Phenotype: involved in transcription regulation, potential role in her2-positive breast cancer. 
ATP1A1	gene symbol: ATP1A1. Functionality: p-type cation transport atpase; na+/k+ gradient maintenance; na-coupled transport; nerve, muscle excitability Phenotype: her2-positive breast cancer; altered ion transport; cellular osmoregulation 
CD81	gene symbol: CD81. Functionality: cell surface glycoprotein, signal transduction, complexes with integrins, regulates cell development, activation, growth, motility. Phenotype: promotes muscle cell fusion, supports myotube maintenance, candidate gene for malignancies, localized in tumor-suppressor gene region. 
SEC61A1	gene symbol: SEC61A1. Functionality: protein translocation, er membrane integration, ribosome association Phenotype: her2-positive breast cancer progression, altered protein processing 
CLDN3	gene symbol: CLDN3. Functionality: integral membrane protein; tight junction component; low-affinity receptor for clostridium perfringens enterotoxin. Phenotype: her2-positive breast cancer; altered cell adhesion; potential involvement in apoptosis. 
PPDPF	gene symbol: PPDPF. Functionality: involved in cell differentiation, torc1 signaling, liver development. Phenotype: her2-positive breast cancer associations, affects mitochondrial function. 
S100A14	gene symbol: S100A14. Functionality: calcium-binding protein, ef-hand motif, tumor suppressor function. Phenotype: lower levels in cancerous tissue, associated with metastasis, her2-positive breast cancer. 
BGN	gene symbol: BGN. Functionality: encodes slrp family protein, involved in bone growth, muscle development, regeneration, collagen assembly, inflammation regulation, and innate immunity. Phenotype: associated with atherosclerosis, aortic valve stenosis, and related to her2-positive breast cancer. 
C3	gene symbol: C3. Functionality: complement system activation, classical and alternative pathways, inflammation modulation, antimicrobial activity. Phenotype: atypical hemolytic uremic syndrome, age-related macular degeneration. 
MZT2B	gene symbol: MZT2B. Functionality: involved in microtubule nucleation; component of gamma-tubulin ring complex; localizes to cytosol, microtubule cytoskeleton, nucleoplasm. Phenotype: her2-positive breast cancer; potential role in cell division and proliferation. 
S100A8	gene symbol: S100A8. Functionality: regulates cellular processes, inhibits casein kinase, acts as cytokine. Phenotype: associated with her2-positive breast cancer, cystic fibrosis. 
MDK	gene symbol: MDK. Functionality: secreted growth factor, binds heparin, responds to retinoic acid, promotes cell growth, migration, angiogenesis, tumorigenesis. Phenotype: her2-positive breast cancer, enhanced tumor proliferation, increased tumor invasiveness, potential therapeutic target. 
PFDN5	gene symbol: PFDN5. Functionality: encodes prefoldin subunit; aids polypeptide folding; represses c-myc transcriptional activity. Phenotype: linked to her2-positive breast cancer; impacts cell growth and protein homeostasis. 
H2AFJ	gene symbol: H2AFJ. Functionality: encodes replication-independent histone variant, antimicrobial activity, nucleosome structure. Phenotype: involvement in chromatin structure, potential impact on her2-positive breast cancer. 
SH3BGRL3	gene symbol: SH3BGRL3. Functionality: cytoskeleton organization, located in cytosol, nuclear body, ruffle membrane. Phenotype: her2-positive breast cancer association. 
ENO1	gene symbol: ENO1. Functionality: glycolytic enzyme, tumor suppressor, structural protein, autoantigen. Phenotype: her2-positive breast cancer, hashimoto encephalopathy. 
XBP1	gene symbol: XBP1. Functionality: regulates mhc class ii genes, binds x box, bzip protein, enhances t cell leukemia virus promoter, activates during er stress via ire1 splicing. Phenotype: contributes to her2-positive breast cancer, influences er stress response, regulates cellular stress pathways. 
CYBA	gene symbol: CYBA. Functionality: encodes light alpha subunit of cytochrome b, part of microbicidal oxidase system in phagocytes. Phenotype: associated with autosomal recessive chronic granulomatous disease, linked to defective superoxide generation in phagocytes. 
COX6B1	gene symbol: COX6B1. Functionality: encodes subunit vib of cytochrome c oxidase, involved in electron transfer and complex assembly regulation. Phenotype: associated with severe infantile encephalomyopathy; potential role in her2-positive breast cancer unknown. 
TRAF4	gene symbol: TRAF4. Functionality: mediates signal transduction in tnf receptor superfamily, regulates nf-kappa b activation, interacts with ntr, involved in mapk8/jnk activation and oxidative stress response. Phenotype: influences her2-positive breast cancer progression, impacts cell death regulation and signal transduction pathways. 
CD24	gene symbol: CD24. Functionality: modulates growth and differentiation signals in granulocytes and b cells. Phenotype: associated with her2-positive breast cancer; affects tumor progression and immune response. 
PRSS8	gene symbol: PRSS8. Functionality: serine protease activity, trypsin-like substrate specificity, epithelial sodium channel activation, epithelial barrier formation Phenotype: altered sodium balance, potential impact on epithelial barrier integrity, related to her2-positive breast cancer 
MMP14	gene symbol: MMP14. Functionality: breaks down extracellular matrix, activates mmp2, involved in tumor invasion. Phenotype: associated with increased tumor invasiveness and metastasis in her2-positive breast cancer. 
MUC1	gene symbol: MUC1. Functionality: membrane-bound mucin protein, forms protective mucous barriers, involved in intracellular signaling, cell adhesion. Phenotype: associated with carcinomas, overexpression, aberrant localization, glycosylation changes, her2-positive breast cancer involvement. 
VIM	gene symbol: VIM. Functionality: encodes type iii intermediate filament protein, maintains cell shape, cytoplasm integrity, stabilizes cytoskeletal interactions, organizes proteins for cell attachment, migration, signaling, involved in neuritogenesis, cholesterol transport. Phenotype: associated with congenital cataracts, bacterial and viral pathogen attachment, implicated in cancer cell migration, her2-positive breast cancer progression. 
MIDN	gene symbol: MIDN. Functionality: molecular adaptor activity, protein catabolic process, cytoplasm, nucleus Phenotype: her2-positive breast cancer involvement, protein degradation 
SPINT2	gene symbol: SPINT2. Functionality: inhibits serine proteases, blocks hgf activator, tumor suppressor role, multiple isoforms. Phenotype: congenital sodium diarrhea, potential involvement in her2-positive breast cancer. 
BST2	gene symbol: BST2. Functionality: involved in bone marrow stromal cell activity, pre-b-cell growth, rheumatoid arthritis, and acts as a viral restriction factor. Phenotype: associates with increased breast cancer aggressiveness in her2-positive cases. 
TIMP1	gene symbol: TIMP1. Functionality: inhibitor of matrix metalloproteinases, promotes cell proliferation, anti-apoptotic, inducible by cytokines and hormones. Phenotype: involved in her2-positive breast cancer, affects extracellular matrix degradation, cell proliferation, and apoptosis. 
GUK1	gene symbol: GUK1. Functionality: catalyzes phosphate transfer from atp to gmp forming gdp. Phenotype: associated with her2-positive breast cancer; potential chemotherapy target. 
ACTN4	gene symbol: ACTN4. Functionality: actin binding, cytoskeletal organization, cell adhesion, metastatic processes Phenotype: her2-positive breast cancer, focal and segmental glomerulosclerosis 
CTSB	gene symbol: CTSB. Functionality: lysosomal cysteine protease; endopeptidase and exopeptidase activity; protein turnover; app processing. Phenotype: alzheimer's disease, esophageal adenocarcinoma, tumor association, her2-positive breast cancer progression. 
COX4I1	gene symbol: COX4I1. Functionality: encodes subunit iv isoform 1 of cytochrome c oxidase, involved in electron transfer and proton gradient in mitochondria. Phenotype: altered expression may affect mitochondrial function and contribute to tumorigenesis in her2-positive breast cancer. 
CCT3	gene symbol: CCT3. Functionality: molecular chaperone; member of cct complex; atp-dependent protein folding; includes actin, tubulin folding. Phenotype: her2-positive breast cancer; potential impact on cell proliferation and survival. 
HNRNPA2B1	gene symbol: HNRNPA2B1. Functionality: rna binding, pre-mrna processing, mrna metabolism, transport Phenotype: her2-positive breast cancer, alternative splicing, rna transport 
SEPW1	gene symbol: SEPW1. Functionality: selenoprotein in redox processes, uga codon, muscle growth, neuronal protection. Phenotype: muscle differentiation, neuron oxidative stress protection. 
LY6E	gene symbol: LY6E. Functionality: gpi-anchored protein involved in t cell physiology, oncogenesis, immunological regulation, viral infection modulation. Phenotype: her2-positive breast cancer, altered t cell function, viral susceptibility. 
SCD	gene symbol: SCD. Functionality: enzyme in fatty acid biosynthesis, oleic acid synthesis, fatty acid desaturase family, integral membrane protein in endoplasmic reticulum. Phenotype: alterations may affect lipid metabolism, associated with cancer progression, her2-positive breast cancer. 
HSPB1	gene symbol: HSPB1. Functionality: molecular chaperone, protein folding, stress response, cell differentiation Phenotype: cancer cell proliferation, metastasis, apoptosis resistance, charcot-marie-tooth disease, distal hereditary motor neuropathy 
EIF4G2	gene symbol: EIF4G2. Functionality: general repressor of translation; forms translationally inactive complexes; binds eif4a, eif3; similar to eif4g. Phenotype: linked to her2-positive breast cancer; affects protein synthesis regulation. 
BSG	gene symbol: BSG. Functionality: plasma membrane protein, spermatogenesis, embryo implantation, neural network formation, tumor progression, immunoglobulin superfamily member. Phenotype: her2-positive breast cancer, tumor proliferation, metastasis potential. 
ZYX	gene symbol: ZYX. Functionality: zyxin is involved in cell adhesion and signal transduction, interacts with sh3 domains, and modulates actin cytoskeleton organization. Phenotype: altered zyxin expression may affect cell migration, invasion, and proliferation, relevant to her2-positive breast cancer progression. 
TUBB	gene symbol: TUBB. Functionality: beta tubulin protein, microtubule structural component, dimerizes with alpha tubulin Phenotype: cortical dysplasia, complex brain malformations, associated with her2-positive breast cancer 
LASP1	gene symbol: LASP1. Functionality: actin-binding, camp/cgmp signaling, src homology, lim motif Phenotype: metastatic breast cancer, b-cell lymphomas, colorectal cancer 
CD99	gene symbol: CD99. Functionality: cell surface glycoprotein involved in leukocyte migration, t-cell adhesion, transmembrane protein transport, actin cytoskeleton rearrangement, caspase-independent t-cell death. Phenotype: oncosuppressor in osteosarcoma, her2-positive breast cancer involvement. 
COL6A2	gene symbol: COL6A2. Functionality: encodes alpha chain of type vi collagen; binds extracellular matrix proteins; organizes matrix components. Phenotype: associated with bethlem myopathy, ullrich scleroatonic muscular dystrophy; related to her2-positive breast cancer. 
H1FX	gene symbol: H1FX. Functionality: encodes replication-independent histone, involved in nucleosome structure, chromatin compaction. Phenotype: altered expression linked to breast cancer, possibly affecting cell proliferation and dna repair. 
RALY	gene symbol: RALY. Functionality: pre-mrna splicing, embryonic development, hnrnp family Phenotype: her2-positive breast cancer, possible role in tumor progression 
UBE2M	gene symbol: UBE2M. Functionality: ubiquitin-conjugating enzyme, nedd8 conjugation, protein degradation, cell cycle regulation. Phenotype: her2-positive breast cancer, abnormal protein degradation, cellular proliferation. 
SPARC	gene symbol: SPARC. Functionality: encodes cysteine-rich protein; involved in collagen calcification, extracellular matrix synthesis, and cell shape changes. Phenotype: tumor suppression, metastasis promotion, and cell invasion in her2-positive breast cancer. 
ATG10	gene symbol: ATG10. Functionality: involved in autophagosome formation, e2-like enzyme, atg12-atg5 conjugation, map-lc3 modification Phenotype: influences her2-positive breast cancer progression, impacts autophagy-related cell survival and proliferation 
HSP90AB1	gene symbol: HSP90AB1. Functionality: protein folding, signal transduction, protein degradation, gastric apoptosis, inflammation. Phenotype: her2-positive breast cancer, altered cellular growth, potential therapeutic target. 
ORMDL3	gene symbol: ORMDL3. Functionality: involved in ceramide metabolism, negative regulation of b cell apoptosis, negative regulation of ceramide biosynthesis, positive regulation of protein localization to nucleus; part of serine palmitoyltransferase complex. Phenotype: may influence her2-positive breast cancer progression through ceramide pathway; affects b cell survival and protein localization. 
LMAN2	gene symbol: LMAN2. Functionality: transmembrane lectin, binds high mannose glycoproteins, facilitates sorting and trafficking. Phenotype: altered glycoprotein processing, potential impact on her2-positive breast cancer progression. 
CHCHD2	gene symbol: CHCHD2. Functionality: regulates mitochondrial apoptosis, translocates under stress, binds oxygen responsive element. Phenotype: impacts mitochondrial apoptosis regulation, affects electron transport chain response. 
COX7C	gene symbol: COX7C. Functionality: encodes subunit viic of cytochrome c oxidase; involved in electron transfer and regulation of mitochondrial respiratory chain. Phenotype: associated with energy production in cells; potential role in her2-positive breast cancer metabolism. 
ARHGDIA	gene symbol: ARHGDIA. Functionality: regulates rho gtpase signaling, inhibits rho gdp dissociation, maintains inactive state. Phenotype: linked to nephrotic syndrome type 8, expression altered in tumors, impacts cell processes. 
VMP1	gene symbol: VMP1. Functionality: regulates autophagy, mediates zymophagy in pancreatitis, triggers autophagy under nutrient-rich conditions. Phenotype: overexpression linked to her2-positive breast cancer, involved in pancreatitis with sequestration and degradation of zymogen granules. 
UBC	gene symbol: UBC. Functionality: polyubiquitin precursor, ubiquitination, protein degradation, dna repair, cell cycle regulation, kinase modification, endocytosis, cell signaling regulation. Phenotype: her2-positive breast cancer involvement, altered protein turnover, disrupted cell cycle, aberrant signaling pathways. 
IGFBP2	gene symbol: IGFBP2. Functionality: binds igf-i and igf-ii, secreted or intracellular, interacts with ligands. Phenotype: promotes tumor growth, affects recovery prediction in her2-positive breast cancer. 
COPE	gene symbol: COPE. Functionality: part of coatomer protein complex; binds dilysine motifs; golgi-to-er retrograde transport. Phenotype: alterations may impact protein transport in cells; potential link to her2-positive breast cancer. 
NUPR1	gene symbol: NUPR1. Functionality: dna binding, transcription coactivator, regulates cell cycle, oxidative phosphorylation, catabolic process. Phenotype: involved in her2-positive breast cancer; influences cell death and proliferation. 
PERP	gene symbol: PERP. Functionality: involved in endopeptidase activity, neutrophil chemotaxis regulation, desmosome and plasma membrane location. Phenotype: linked to erythrokeratodermia variabilis, mutilating palmoplantar keratoderma, her2-positive breast cancer. 
KRT81	gene symbol: KRT81. Functionality: type ii hair keratin; heterodimerizes with type i keratins; forms hair, nails. Phenotype: expressed in hair cortex; mutations linked to monilethrix; related to hair follicle disorders. 
PPP1R1B	gene symbol: PPP1R1B. Functionality: bifunctional signal transduction; regulates phosphorylation; kinase inhibitor; phosphatase inhibitor; target for dopamine. Phenotype: her2-positive breast cancer; neurologic disorders; psychiatric disorders. 
LGALS3BP	gene symbol: LGALS3BP. Functionality: beta-galactoside-binding protein; modulates cell-cell/matrix interactions; involved in immune response; binds mac-2, galectin 1. Phenotype: elevated in cancer, hiv patients; implicated in her2-positive breast cancer; affects nk and lak cell cytotoxicity. 
SSR2	gene symbol: SSR2. Functionality: er membrane receptor, protein translocation, glycosylated, 22-kd glycoprotein Phenotype: her2-positive breast cancer involvement 
KIAA0100	gene symbol: KIAA0100. Functionality: involved in breast and prostate cancer; regulated by mir-195; encodes several isoforms with rna pol ii promoter fmp27 and golgi-body-localization apt1 domains. Phenotype: high expression in breast carcinoma and prostate cancer; associated with cancer invasiveness and metastasis; antigen on acute monocytic leukemia cells in mice. 
MYL9	gene symbol: MYL9. Functionality: regulates muscle contraction, modulates atpase activity, binds calcium, activated by myosin light chain kinase. Phenotype: associated with her2-positive breast cancer progression. 
CIB1	gene symbol: CIB1. Functionality: calcium-binding protein, interacts with integrin, dna-dependent kinase, presenilin-2, focal adhesion kinase, p21 activated kinase, protein kinase d, involved in cell survival, proliferation. Phenotype: her2-positive breast cancer association, cell survival, proliferation, alzheimer's disease linkage. 
IDH2	gene symbol: IDH2. Functionality: catalyzes oxidative decarboxylation of isocitrate to 2-oxoglutarate, nadp(+)-dependent, mitochondrial, energy metabolism. Phenotype: altered idh2 may affect cellular metabolism, linked to her2-positive breast cancer. 
STARD10	gene symbol: STARD10. Functionality: lipid binding and transport, regulates peroxisome proliferator activated receptor signaling. Phenotype: involved in her2-positive breast cancer, affects lipid metabolism and tumor progression. 
LGALS1	gene symbol: LGALS1. Functionality: beta-galactoside-binding, modulates cell-cell and cell-matrix interactions, regulates cell proliferation. Phenotype: her2-positive breast cancer, potential autocrine negative growth factor effects. 
COX6C	gene symbol: COX6C. Functionality: electron transfer regulation, assembly of cytochrome c oxidase complex. Phenotype: up-regulation in cancer cells, association with her2-positive breast cancer. 
GRN	gene symbol: GRN. Functionality: regulates cell growth, development, wound healing, tumorigenesis. Phenotype: may influence tumor growth in her2-positive breast cancer. 
MAPKAPK2	gene symbol: MAPKAPK2. Functionality: ser/thr protein kinase; regulated by p38 map kinase; involved in stress response, inflammatory response, nuclear export, gene expression regulation, cell proliferation; phosphorylates hsp27; two isoforms. Phenotype: in her2-positive breast cancer, mapkapk2 may influence tumor progression by regulating stress and inflammatory pathways, affecting cell proliferation and survival. 
GNAI2	gene symbol: GNAI2. Functionality: guanine nucleotide binding, hormonal regulation of adenylate cyclase, g protein signaling. Phenotype: her2-positive breast cancer, altered cell signaling, potential impact on tumor growth. 
KDELR1	gene symbol: KDELR1. Functionality: er lumen protein retention; kdel receptor; protein retrieval from golgi. Phenotype: her2-positive breast cancer; er protein retention disruption; altered protein localization. 
COL18A1	gene symbol: COL18A1. Functionality: encodes type xviii collagen, involved in extracellular matrix structure, angiogenesis inhibition, and proteolytic processing producing endostatin. Phenotype: associated with knobloch syndrome; involves retinal abnormalities and neural tube defects; impacts angiogenesis and tumor growth. 
UQCRQ	gene symbol: UQCRQ. Functionality: encodes a protein involved in electron transport in mitochondrial respiratory chain, part of complex iii. Phenotype: altered expression may affect mitochondrial function, potentially impacting cellular energy metabolism in her2-positive breast cancer. 
COX5B	gene symbol: COX5B. Functionality: mitochondrial respiratory chain enzyme subunit, electron transfer, proton gradient contribution. Phenotype: her2-positive breast cancer association, potential impact on tumor cell energy metabolism. 
ELOVL1	gene symbol: ELOVL1. Functionality: fatty acid elongase activity, fatty acid biosynthesis, sphingolipid biosynthesis Phenotype: potential impact on cancer cell membrane composition and signaling in her2-positive breast cancer 
CHPF	gene symbol: CHPF. Functionality: enables n-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase and glucuronosyl-n-acetylgalactosaminyltransferase activities; involved in chondroitin sulfate and polysaccharide chain biosynthesis; located in golgi membrane. Phenotype: related to her2-positive breast cancer; impacts proteoglycan biosynthesis affecting cancer cell growth and metastasis. 
CLDN4	gene symbol: CLDN4. Functionality: encodes claudin protein; component of epithelial cell tight junctions; regulates solute movement; receptor for clostridium perfringens enterotoxin. Phenotype: associated with her2-positive breast cancer; involved in organ development; implicated in williams-beuren syndrome. 
C12orf57	gene symbol: C12orf57. Functionality: ubiquitous expression, involved in corpus callosum development, alternative splicing. Phenotype: associated with temtamy syndrome, linked to neurological development issues. 
LGALS3	gene symbol: LGALS3. Functionality: carbohydrate binding, apoptosis, innate immunity, cell adhesion, t-cell regulation, antimicrobial activity. Phenotype: altered immune response, potential role in tumor progression, implications in her2-positive breast cancer. 
HSP90AA1	gene symbol: HSP90AA1. Functionality: inducible molecular chaperone, assists protein folding via atpase activity, modulated by co-chaperones. Phenotype: her2-positive breast cancer association, impacts cell proliferation and survival pathways, influences treatment response. 
JUP	gene symbol: JUP. Functionality: cytoplasmic protein, desmosome and intermediate junctions, complexes with cadherins, armadillo repeat, catenin family. Phenotype: associated with naxos disease, involved in cell adhesion, her2-positive breast cancer. 
A2M	gene symbol: A2M. Functionality: protease inhibitor, cytokine transporter, mediates clearance of a-beta. Phenotype: alpha-2-macroglobulin deficiency, involvement in alzheimer's disease. 
NDUFB7	gene symbol: NDUFB7. Functionality: subunit of nadh:ubiquinone oxidoreductase, mitochondrial electron transport, nadh dehydrogenase activity. Phenotype: implicated in energy metabolism; potential role in her2-positive breast cancer pathogenesis. 
PGAP3	gene symbol: PGAP3. Functionality: gpi-specific phospholipase, golgi apparatus, seven-transmembrane protein, removes unsaturated fatty acids, gpi-anchored proteins, lipid rafts, protein sorting, trafficking. Phenotype: her2-positive breast cancer, neurologic hyperphosphatasia, cognitive disability, hpmrs4. 
HSPA8	gene symbol: HSPA8. Functionality: chaperone for protein folding, atpase in vesicle transport Phenotype: her2-positive breast cancer progression 
TCEB2	gene symbol: TCEB2. Functionality: regulatory subunit in transcription factor b complex, modulates rna polymerase ii elongation. Phenotype: involvement in transcription elongation; interacts with vhl tumor suppressor, potentially impacting tumorigenesis. 
PEBP1	gene symbol: PEBP1. Functionality: modulates mapk, nf-kappa b, gsk-3 pathways; involved in neural development; metastasis suppressor. Phenotype: implications in her2-positive breast cancer; neural development impact. 
COPS9	gene symbol: COPS9. Functionality: involved in cellular response to uv, cytoplasmic protein sequestering, negative regulation of protein neddylation. Phenotype: associated with her2-positive breast cancer. 
ATP5G2	gene symbol: ATP5G2. Functionality: encodes subunit c of mitochondrial atp synthase involved in atp synthesis through oxidative phosphorylation. Phenotype: her2-positive breast cancer associated due to altered energy metabolism and cell proliferation. 
ATP6AP1	gene symbol: ATP6AP1. Functionality: component of v-atpase enzyme, mediates acidification of organelles, involved in protein sorting, zymogen activation, receptor-mediated endocytosis. Phenotype: her2-positive breast cancer, potential impact on acidification processes, involvement in early development. 
MYH9	gene symbol: MYH9. Functionality: non-muscle myosin heavy chain iia involved in cytokinesis, cell motility, cell shape maintenance. Phenotype: associated with her2-positive breast cancer, non-syndromic sensorineural deafness, epstein syndrome, alport syndrome, sebastian syndrome, fechtner syndrome, macrothrombocytopenia. 
LSM4	gene symbol: LSM4. Functionality: rna-binding, u6 snrna binding, pre-mrna splicing, u4/u6 snrnp formation Phenotype: her2-positive breast cancer 
COX8A	gene symbol: COX8A. Functionality: terminal enzyme in respiratory chain, electron transfer, proton gradient. Phenotype: her2-positive breast cancer, altered oxidative phosphorylation. 
UQCR11	gene symbol: UQCR11. Functionality: component of ubiquinol-cytochrome c reductase complex in mitochondrial respiratory chain, may bind iron-sulfur protein. Phenotype: not directly linked to her2-positive breast cancer; involved in cellular energy metabolism. 
ATP5B	gene symbol: ATP5B. Functionality: encodes beta subunit of mitochondrial atp synthase catalytic core, involved in atp synthesis during oxidative phosphorylation. Phenotype: potential impact on energy metabolism, cell proliferation, and survival in her2-positive breast cancer. 
DHCR24	gene symbol: DHCR24. Functionality: catalyzes reduction of delta-24 double bond in sterol intermediates during cholesterol biosynthesis. Phenotype: associated with desmosterolosis, altered expression in alzheimers and adrenal gland cancer; contributes to her2-positive breast cancer. 
PTBP1	gene symbol: PTBP1. Functionality: rna-binding; pre-mrna splicing; mrna metabolism; protein degradation; ubiquitin-proteasome pathway Phenotype: her2-positive breast cancer proliferation; tumor progression 
EIF3B	gene symbol: EIF3B. Functionality: rna binding, translation initiation, viral translational processes, stress granule localization, eukaryotic translation initiation factor 3 complex component Phenotype: associated with her2-positive breast cancer, affects cell proliferation, tumor growth 
NDUFA3	gene symbol: NDUFA3. Functionality: mitochondrial respiratory chain complex i assembly; mitochondrial inner membrane component; electron transport. Phenotype: her2-positive breast cancer may involve altered mitochondrial function affecting energy production and cell growth. 
FKBP2	gene symbol: FKBP2. Functionality: protein folding, trafficking, immunoregulation, er chaperone, prolyl isomerase activity Phenotype: potentially related to her2-positive breast cancer due to role in protein regulation and cellular processes 
MMACHC	gene symbol: MMACHC. Functionality: involved in cobalamin binding and intracellular trafficking, possibly linked to energy transduction. Phenotype: associated with methylmalonic aciduria and homocystinuria type cblc. 
RABAC1	gene symbol: RABAC1. Functionality: enables identical protein binding activity, involved in intracellular transport. Phenotype: associated with her2-positive breast cancer, potentially impacting cell signaling and growth. 
ISG15	gene symbol: ISG15. Functionality: ubiquitin-like protein conjugation, interferon activation, chemotactic activity, signaling, antiviral activity. Phenotype: altered immune response, potential implications in her2-positive breast cancer. 
PTMA	gene symbol: PTMA. Functionality: dna-binding transcription factor binding, histone binding, negative regulation of apoptosis Phenotype: potential involvement in cell survival, proliferation, her2-positive breast cancer progression 
RRBP1	gene symbol: RRBP1. Functionality: encodes er membrane ribosome-binding protein, influences er proliferation, secretory pathways, cell differentiation, er-microtubule interactions, alternative splicing affects ribosome-binding and secretory function. Phenotype: associated with her2-positive breast cancer, variations may impact cancer cell secretory pathways and differentiation. 
POSTN	gene symbol: POSTN. Functionality: extracellular matrix protein in tissue development, regeneration, cell adhesion, migration, cancer stem cell maintenance, metastasis. Phenotype: her2-positive breast cancer, cardiac valve disease, skeletal, dental defects. 
C1QB	gene symbol: C1QB. Functionality: encodes b-chain of serum complement c1q, part of complement system, involved in immune complex clearance. Phenotype: associated with lupus erythematosus, glomerulonephritis, impacts immune response and inflammation. 
BCAP31	gene symbol: BCAP31. Functionality: transmembrane protein in er, anterograde transport to golgi, caspase 8-mediated apoptosis. Phenotype: associated with her2-positive breast cancer, cadds, multiple transcript variants, chromosome 16 pseudogenes. 
PSMB4	gene symbol: PSMB4. Functionality: part of proteasome complex; atp/ubiquitin-dependent peptide cleavage; involved in mhc class i peptide processing. Phenotype: associated with her2-positive breast cancer; potential role in cancer progression and immune response. 
LAPTM4A	gene symbol: LAPTM4A. Functionality: involved in transport of small molecules across endosomal and lysosomal membranes Phenotype: her2-positive breast cancer progression 
INTS1	gene symbol: INTS1. Functionality: subunit of integrator complex, mediates 3-prime end processing of small nuclear rnas, associates with rna polymerase ii. Phenotype: potential involvement in her2-positive breast cancer through rna processing regulation. 
FNBP1L	gene symbol: FNBP1L. Functionality: binds cdc42, n-wasp; promotes actin polymerization; activates n-wasp-wip complex; links cell signals to cytoskeleton. Phenotype: involved in cell migration, invasion; potential role in her2-positive breast cancer progression. 
JTB	gene symbol: JTB. Functionality: protein kinase binding; mitotic cytokinesis; regulation of protein kinase activity. Phenotype: her2-positive breast cancer association; cell proliferation; tumor progression. 
NBL1	gene symbol: NBL1. Functionality: bmp antagonist, ctck motif, secreted protein, binds bmps, growth, development. Phenotype: her2-positive breast cancer, growth suppression, tumor progression inhibition. 
HM13	gene symbol: HM13. Functionality: intramembrane proteolysis, signal peptide cleavage, immune recognition. Phenotype: her2-positive breast cancer, immune system interactions, viral processing. 
SLC2A4RG	gene symbol: SLC2A4RG. Functionality: nuclear transcription factor, activates slc2a4, interacts with mef2. Phenotype: her2-positive breast cancer, altered glucose transport regulation. 
ROMO1	gene symbol: ROMO1. Functionality: mitochondrial membrane protein, increases ros, antimicrobial activity. Phenotype: her2-positive breast cancer, ros-related cellular changes. 
SERINC2	gene symbol: SERINC2. Functionality: enables acetyltransferase activator activity and is involved in phosphatidylserine metabolism. Phenotype: altered expression may influence breast cancer progression and response to her2-targeted therapies. 
NDUFA11	gene symbol: NDUFA11. Functionality: encodes a subunit of mitochondrial complex i; nadh-ubiquinol reductase activity; electron transport. Phenotype: mitochondrial complex i deficiency; possible impact on cellular energy production. 
RHOC	gene symbol: RHOC. Functionality: encodes rho family gtpase; cycles between gdp/gtp states; modulates actin cytoskeleton; regulates cell shape, attachment, motility; involved in signal transduction. Phenotype: overexpression linked to tumor proliferation, metastasis; associated with her2-positive breast cancer; influences cell locomotion; localizes to cytoplasm, plasma membrane. 
TXNIP	gene symbol: TXNIP. Functionality: inhibits thioredoxin antioxidative function; regulates cellular redox signaling, metabolism, er stress; possible tumor suppressor. Phenotype: accumulation of reactive oxygen species; cellular stress; potential role in her2-positive breast cancer suppression. 
TYMP	gene symbol: TYMP. Functionality: encodes angiogenic factor promoting angiogenesis, stimulating endothelial cell growth, associated with mitochondrial neurogastrointestinal encephalomyopathy. Phenotype: involvement in her2-positive breast cancer through angiogenesis, contributing to tumor growth and metastasis. 
NACA	gene symbol: NACA. Functionality: associates with btf3 to form nac, binds nascent proteins, blocks srp interaction, prevents er mistranslocation. Phenotype: ige autoantigen in atopic dermatitis, associated with her2-positive breast cancer. 
HSP90B1	gene symbol: HSP90B1. Functionality: atp-metabolizing molecular chaperone, protein stabilization, folding Phenotype: tumor formation, pathogenic states 
SNRPB	gene symbol: SNRPB. Functionality: involved in pre-mrna splicing, part of u1, u2, u4/u6, u5 snrnp particles, may affect snrnp structure. Phenotype: associated with autoantibody recognition in systemic lupus erythematosus, potential role in her2-positive breast cancer pathology. 
PFKL	gene symbol: PFKL. Functionality: catalyzes conversion of d-fructose 6-phosphate to d-fructose 1,6-bisphosphate in glycolysis. Phenotype: altered glycolysis in her2-positive breast cancer cells. 
VCP	gene symbol: VCP. Functionality: protein degradation, intracellular membrane fusion, dna repair, cell cycle regulation, nf-kappa b activation Phenotype: her2-positive breast cancer, ibmpfd, als, charcot-marie-tooth disease 
ERGIC1	gene symbol: ERGIC1. Functionality: membrane protein; er-golgi transport; protein turnover regulation. Phenotype: no direct phenotype; non-cancer specific; potential role in protein transport affects cell proliferation. 
NUCKS1	gene symbol: NUCKS1. Functionality: nuclear protein, dna-binding, phosphorylated by cdk1, involved in cell cycle mitosis. Phenotype: associated with her2-positive breast cancer progression. 
PSMD8	gene symbol: PSMD8. Functionality: non-atpase subunit of 19s regulator in 26s proteasome. Phenotype: potential role in protein degradation affecting her2-positive breast cancer. 
CALM2	gene symbol: CALM2. Functionality: calcium binding, signaling pathways, cell cycle progression, proliferation. Phenotype: long-qt syndrome, ventricular arrhythmias, neurodevelopmental delay, epilepsy. 
AP2S1	gene symbol: AP2S1. Functionality: encodes small chain of ap-2 complex, involved in clathrin-mediated endocytosis. Phenotype: altered ap2s1 function affects receptor internalization, potentially impacting her2 signaling in cancer. 
DBI	gene symbol: DBI. Functionality: cholesterol transport into mitochondria, interaction with benzodiazepines, steroid hormone synthesis initiation. Phenotype: her2-positive breast cancer association, mitochondrial compartment expression. 
C4orf48	gene symbol: C4orf48. Functionality: mrna 3'-utr binding, mrna stabilization, spermatogenesis Phenotype: her2-positive breast cancer association 
SDF4	gene symbol: SDF4. Functionality: encodes stromal cell-derived factor, member of crec family, contains six ef-hand and calcium-binding motifs, localizes to golgi lumen, regulates calcium-dependent cellular activities. Phenotype: associated with her2-positive breast cancer, potentially influences tumorigenesis and cancer cell proliferation. 
TPI1	gene symbol: TPI1. Functionality: catalyzes isomerization of g3p and dhap in glycolysis and gluconeogenesis. Phenotype: associated with triosephosphate isomerase deficiency, impacting energy metabolism. 
